# NeoAdapt 3: Novel Biomarkers in the Evaluation of Neonatal Circulatory Insufficiency in Babies Suffering From Hypoxic Ischemic Encephalopathy

> **NCT02051894** · — · COMPLETED · sponsor: **Brighton and Sussex University Hospitals NHS Trust** · enrollment: 18 (actual)

## Conditions studied

- Circulatory Failure

## Interventions

- **DRUG:** Dobutamine

## Key facts

- **NCT ID:** NCT02051894
- **Lead sponsor:** Brighton and Sussex University Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02051894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02051894, "NeoAdapt 3: Novel Biomarkers in the Evaluation of Neonatal Circulatory Insufficiency in Babies Suffering From Hypoxic Ischemic Encephalopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02051894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*